Price Alert

Mirum Pharmaceuticals Inc... (MIRM)

NASDAQ: MIRM · Real-Time Price · USD

72.76

-0.81 (-1.10%)

At close: Sep 26, 2025, 3:59 PM

73.19

0.59%

After-hours: Sep 26, 2025, 04:15 PM EDT

Mirum Pharmaceuticals Statistics

Share Statistics

Mirum Pharmaceuticals has 50.24M shares outstanding. The number of shares has increased by 3.83% in one year.

Shares Outstanding	50.24M
Shares Change (YoY)	3.83%
Shares Change (QoQ)	1.06%
Owned by Institutions (%)	99.99%
Shares Floating	39.98M
Failed to Deliver (FTD) Shares	121
FTD / Avg. Volume	0.02%

Short Selling Information

The latest short interest is 7.5M, so 14.93% of the outstanding shares have been sold short.

Short Interest	7.5M
Short % of Shares Out	14.93%
Short % of Float	14.93%
Short Ratio (days to cover)	14.13

Valuation Ratios

The PE ratio is -22.35 and the forward PE ratio is 613.08. Mirum Pharmaceuticals's PEG ratio is 0.42.

PE Ratio	-22.35
Forward PE	613.08
PS Ratio	5.83
Forward PS	6
PB Ratio	8.71
P/FCF Ratio	210.57
PEG Ratio	0.42

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Mirum Pharmaceuticals.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.1, with a Debt / Equity ratio of 1.41.

Current Ratio	3.1
Quick Ratio	2.93
Debt / Equity	1.41
Debt / EBITDA	-6.49
Debt / FCF	34.05
Interest Coverage	-6.12

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$1.01M
Profits Per Employee	$-263.3K
Employee Count	334
Asset Turnover	0.5
Inventory Turnover	3.64

Taxes

Income Tax	1.03M
Effective Tax Rate	-1.19%

Stock Price Statistics

The stock price has increased by 87.28% in the last 52 weeks. The beta is 0.93, so Mirum Pharmaceuticals's price volatility has been higher than the market average.

Beta	0.93
52-Week Price Change	87.28%
50-Day Moving Average	66.08
200-Day Moving Average	50.92
Relative Strength Index (RSI)	53.12
Average Volume (20 Days)	683,995

Income Statement

In the last 12 months, Mirum Pharmaceuticals had revenue of 336.89M and earned -87.94M in profits. Earnings per share was -1.85.

Revenue	336.89M
Gross Profit	255.25M
Operating Income	-87.61M
Net Income	-87.94M
EBITDA	-48.97M
EBIT	-72.6M
Earnings Per Share (EPS)	-1.85

Full Income Statement

Balance Sheet

The company has 222.5M in cash and 317.76M in debt, giving a net cash position of -95.26M.

Cash & Cash Equivalents	222.5M
Total Debt	317.76M
Net Cash	-95.26M
Retained Earnings	-644.18M
Total Assets	725.83M
Working Capital	308.6M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.32M and capital expenditures -993K, giving a free cash flow of 9.33M.

Operating Cash Flow	10.32M
Capital Expenditures	-993K
Free Cash Flow	9.33M
FCF Per Share	0.2

Full Cash Flow Statement

Margins

Gross margin is 75.77%, with operating and profit margins of -26% and -26.1%.

Gross Margin	75.77%
Operating Margin	-26%
Pretax Margin	-25.8%
Profit Margin	-26.1%
EBITDA Margin	-14.54%
EBIT Margin	-26%
FCF Margin	2.77%

Dividends & Yields

MIRM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for MIRM is $80.5, which is 10.6% higher than the current price. The consensus rating is "Buy".

Price Target	$80.5
Price Target Difference	10.6%
Analyst Consensus	Buy
Analyst Count	10

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	4.36
Piotroski F-Score	4